,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,179,1,1,,492937,27924,Active,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
1,328,1,1,,139224,27924,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,880,2,1,,26755285,27924,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
3,880,2,1,,26755285,27924,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
4,881,2,2,,26755285,27924,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
5,894,2,1,,26755285,27924,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
6,940,1,2,,26613354,27924,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
7,999,1,1,,46487935,27924,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor Using a Diverse Compound Set,Screening,,
8,1004,1,1,,46487935,27924,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression Using a Diverse Compound Set,Screening,,
9,1030,2,1,,26755285,27924,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
10,1379,1,2,,26755285,27924,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
11,1422,1,1,,26613354,27924,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
12,1452,1,1,,26755285,27924,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
13,1457,1,1,,26755285,27924,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
14,1460,1,3,,26755285,27924,Inconclusive,92096784.0,4137.0,19.9526,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
15,1463,1,1,,26755285,27924,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
16,1467,1,3,,26755285,27924,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
17,1468,1,1,,26755285,27924,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
18,1469,1,1,,26755285,27924,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
19,1471,2,1,,26755285,27924,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
20,1476,2,1,,26755285,27924,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
21,1477,1,1,,26755285,27924,Inconclusive,,,3.1623,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
22,1478,2,1,,26755285,27924,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
23,1479,1,2,,26755285,27924,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
24,1490,2,1,,26755285,27924,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
25,1766,1,1,,26755285,27924,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
26,1766,1,1,,26755285,27924,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
27,1768,1,1,,26755285,27924,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
28,1768,1,1,,26755285,27924,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
29,1865,1,1,,26755285,27924,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
30,1948,1,1,,26755285,27924,Inactive,,,35.4813,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
31,2101,1,1,,26755285,27924,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
32,2107,1,1,,26755285,27924,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
33,2112,1,1,,26755285,27924,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
34,2240,1,1,,85787273,27924,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
35,2241,1,1,,85787273,27924,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
36,2275,1,1,,85787273,27924,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
37,2313,1,1,,85787273,27924,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
38,2314,1,2,,26755285,27924,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
39,2314,1,2,,26755285,27924,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
40,2315,1,2,,26755285,27924,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
41,2315,1,2,,26755285,27924,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
42,2316,1,1,,85787273,27924,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
43,2322,1,1,,85787273,27924,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
44,2330,1,1,,85787273,27924,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
45,2451,1,2,,26755285,27924,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
46,2472,1,2,,26755285,27924,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
47,2517,2,1,,26755285,27924,Inconclusive,6980812.0,,0.8913,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
48,2528,1,2,,26755285,27924,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
49,2546,1,1,,26755285,27924,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
50,2549,1,1,,26755285,27924,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
51,2551,1,1,,26755285,27924,Inconclusive,188536040.0,19885.0,10.0,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
52,80963,3,4,,103283166,27924,Unspecified,,,,,Tested for superoxide (O2-) generation inducing activity in differentiated HL-60 cells at 10e-7 M,Other,11266178.0,
53,164825,3,11,,103283166,27924,Unspecified,400135.0,5581.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
54,164825,3,11,,103283166,27924,Unspecified,462455.0,5582.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
55,164825,3,11,,103283166,27924,Unspecified,12230239.0,23683.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
56,164825,3,11,,103283166,27924,Unspecified,20141488.0,5579.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
57,164825,3,11,,103283166,27924,Unspecified,20141582.0,5588.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
58,164825,3,11,,103283166,27924,Unspecified,68067736.0,5590.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
59,164825,3,11,,103283166,27924,Unspecified,205371776.0,5580.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
60,164825,3,11,,103283166,27924,Unspecified,209572639.0,5587.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
61,164825,3,11,,103283166,27924,Unspecified,239938658.0,5584.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
62,164825,3,11,,103283166,27924,Unspecified,281185512.0,5583.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
63,164825,3,11,,103283166,27924,Unspecified,317373571.0,5578.0,,,"Activation of partially purified HeLa cell protein kinase C, 32P incorporation into calf thymus histone(III-S).",Other,1875340.0,
64,164962,8,2,,103283166,27924,Active,,,0.01,IC50,Inhibition of [3H]PDBu binding to murine brain PKC (protein kinase C),Confirmatory,2362276.0,
65,218662,8,5,,103283166,27924,Active,317373571.0,5578.0,0.0025,Ki,"Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha",Confirmatory,11327599.0,
66,218937,8,5,,103283166,27924,Active,400135.0,5581.0,0.00045,Ki,"Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C epsilon",Confirmatory,11327599.0,
67,220518,8,5,,103283166,27924,Active,205371776.0,5580.0,0.0008,Ki,"Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C delta",Confirmatory,11327599.0,
68,220908,8,5,,103283166,27924,Active,20141488.0,5579.0,0.0018,Ki,"Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C beta",Confirmatory,11327599.0,
69,221443,3,3,,103283166,27924,Unspecified,,,,,"Activity against TPA-induced epidermal hyperplasia in mice, and epidermal thickness value was reported",Other,11831905.0,
70,221771,8,5,,103283166,27924,Active,462455.0,5582.0,0.0049,Ki,"Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C gamma",Confirmatory,11327599.0,
71,280058,8,1,,103283166,27924,Active,,,0.00085,EC50,Inhibition of cell proliferation in WEHI231 cell line after 48 hrs,Confirmatory,17284021.0,
72,280060,8,1,,103283166,27924,Active,,,0.00045,EC50,Induction of attachment of U937 cells after 48 hrs,Confirmatory,17284021.0,
73,282117,3,5,,103283166,27924,Active,,,,,Activation of ERK in wild type mouse thymocytes at 100 nM,Other,15588099.0,
74,282118,3,5,,103283166,27924,Inactive,,,,,Activation of ERK in knockout mouse RasGRP1- mutant thymocytes,Other,15588099.0,
75,282119,3,4,,103283166,27924,Inactive,,,,,Accumulation of Ras-GTP level in Rat2 cells expressing empty pBabePuro vector,Other,15588099.0,
76,282120,3,4,,103283166,27924,Active,,,,,Induction of increase in Ras-GTP level in Rat2 cells expressing human Ras-GTP1 at 100 nM,Other,15588099.0,
77,282121,3,5,,103283166,27924,Active,,,,,Increase in ERK phosphorylation in Rat2 cells expressing human Ras-GTP1 at 100 nM,Other,15588099.0,
78,282122,3,10,,103283166,27924,Active,166987610.0,10125.0,,,Induction of translocation of RasGRP1 to plasma membrane in HEK293 cells,Other,15588099.0,
79,282123,3,5,,103283166,27924,Active,,,,,Induction of T cell activation marker CD69 expression in Jurkat T cells at 100 nM,Other,15588099.0,
80,282124,3,5,,103283166,27924,Active,,,,,Induction of T cell activation marker CD69 expression in PBL cells,Other,15588099.0,
81,282125,3,5,,103283166,27924,Active,,,,,Induction of T cell activation marker CD69 expression in concanavalin-A activated CD4+ mouse spleen lymphocytes,Other,15588099.0,
82,282126,3,5,,103283166,27924,Active,,,,,Induction of T cell activation marker CD69 expression in concanavalin-A activated CD8+ mouse spleen lymphocytes,Other,15588099.0,
83,296501,3,4,,103283166,27924,Unspecified,,,,,Induction of HIV-LTR transactivation assessed by GFP expression in Jurkat cells at 10 ng/ml after 36 hrs by flow cytometry,Other,17481906.0,
84,327061,6,3,,103283166,27924,Unspecified,,,,,Cytotoxicity against BALB/c mouse 3T3 cells,Other,18163590.0,
85,327069,6,2,,103283166,27924,Unspecified,,,,,Cytotoxicity against human K562 cells,Other,18163590.0,
86,334631,6,1,,103283166,27924,Unspecified,,,,,Skin irritant activity in SIM mouse ear assessed as irritation unit per ear after 24 hrs,Other,3236005.0,
87,334632,5,4,,103283166,27924,Unspecified,,,,,Skin irritant activity in NMRI mouse ear assessed as irritant dose 50 per ear after 24 hrs,Other,3236005.0,
88,334633,4,4,,103283166,27924,Unspecified,,,,,Skin irritant activity in NMRI mouse ear assessed as irritancy 50 after 24 hrs,Other,3236005.0,
89,334931,3,4,,103283166,27924,Active,,,,,Displacement of [3H]TPA from TPA receptor in ICR mouse epidermal particulate fraction by Me2CO filter method,Other,2853205.0,
90,336961,3,4,,103283166,27924,Active,,,,,Displacement of [3H]TPA from TPA receptor in ICR mouse dorsal epidermis,Other,2558164.0,
91,357337,4,2,,103283166,27924,Unspecified,,,,,Toxicity in mouse assessed as irritant dose causing ear redness after 24 hours by inflammation assay,Other,11520228.0,
92,357338,4,2,,103283166,27924,Unspecified,,,,,Toxicity in mouse assessed as irritant dose causing ear redness after 4 hours by inflammation assay,Other,11520228.0,
93,378387,3,4,,103283166,27924,Active,,,,,Induction of human HL-60 cell adhesion after 48 hrs,Other,10075762.0,
94,378388,3,4,,103283166,27924,Active,,,,,Induction of TNFalpha release from human HL-60 cells after 24 hrs by ELISA,Other,10075762.0,
95,378389,5,1,,103283166,27924,Active,,,0.015,ED50,Activation of rabbit brain PKC assessed as [32P] incorporation in histone 3-S from [gamma32P]ATP,Confirmatory,10075762.0,
96,378390,4,3,,103283166,27924,Active,,,0.015,IC50,Displacement of [3H]PDBu from partially purified rabbit brain PKC,Confirmatory,10075762.0,
97,378689,3,3,,103283166,27924,Unspecified,,,,,Carcinogenesis in CD1 mouse skin assessed as tumor incidence at 4 nmol twice a week for 20 weeks,Other,10075762.0,
98,380908,4,3,,103283166,27924,Unspecified,,,,,Toxicity against Swiss-Webster mouse assessed as irritation in ear per 5 ul after 4 hrs,Other,469552.0,
99,380909,4,3,,103283166,27924,Unspecified,,,,,Toxicity against Swiss-Webster mouse assessed as irritation in ear per 5 ul after 24 hrs,Other,469552.0,
100,434959,1,1,,85787273,27924,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
101,458315,8,1,,103283166,27924,Active,,,5.17,EC50,Binding affinity to GST-tagged PKCdelta expressed in Escherichia coli BL21(DE3) by fluorescence quenching,Confirmatory,20100661.0,
102,458316,8,1,,103283166,27924,Active,,,5.56,EC50,Binding affinity to GST-tagged PKCepsilon expressed in Escherichia coli BL21(DE3) by fluorescence quenching,Confirmatory,20100661.0,
103,458317,8,1,,103283166,27924,Active,,,3.19,EC50,Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching,Confirmatory,20100661.0,
104,464279,3,4,,103283166,27924,Active,,,,,Activation of latent recombinant HIV1 LTR-GFP gene expression infected in human Jurkat LAT-GFP cells assessed as GFP positive cells after 6 hrs by flow cytometry relative to control,Other,20121237.0,
105,485281,1,1,,26755285,27924,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
106,485290,1,1,,26755285,27924,Inactive,20150581.0,,63.0957,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
107,485350,1,2,,99300960,27924,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
108,493033,1,2,,99300960,27924,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
109,493162,1,2,,99302480,27924,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
110,501122,2,3,,103283166,27924,Unspecified,,,,,"Activation of PKC signaling in human HUES8 cells assessed as increase in Pdx1-expressing cells at 14 nM after 4 days by immunocytochemistry pregrown in medium with Wnt3a, activin A, FGF10, KAAD-cyclopamine and retinoic acid relative to ILV treated cells",Other,19287398.0,
111,501124,2,3,,103283166,27924,Unspecified,,,,,Activation of PKC signaling in human HUES8 definitive endoderm cells assessed as increase in Pdx1-expressing cells at 14 nM after 4 days by immunocytochemistry (Rvb = 2.8+/-0.6%),Other,19287398.0,
112,504327,1,1,,26755285,27924,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
113,504332,1,1,,26755285,27924,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
114,504847,1,1,,26755285,27924,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
115,517254,2,4,,103283166,27924,Unspecified,,,,,Induction of EBA-early antigen production in human Raji cells at 10'-7 M,Other,20817520.0,
116,517255,1,4,,103283166,27924,Inconclusive,,,,,Cytotoxicity against human Raji cells assessed as viability at 1 uM in presence of TPA,Other,20817520.0,
117,517256,1,4,,103283166,27924,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as viability at 1 uM,Other,20817520.0,
118,517257,1,4,,103283166,27924,Inconclusive,,,,,Cytotoxicity against human Raji cells assessed as viability at 10'-7 M in presence of TPA,Other,20817520.0,
119,517258,1,4,,103283166,27924,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as viability at 10'-7 M,Other,20817520.0,
120,517259,2,4,,103283166,27924,Inconclusive,,,,,Inhibition of TPA-induced EBA-early antigen production in human Raji cells at 1 uM,Other,20817520.0,
121,517260,2,4,,103283166,27924,Unspecified,,,,,Induction of EBA-early antigen production in human Raji cells at 1 uM,Other,20817520.0,
122,517261,2,4,,103283166,27924,Inconclusive,,,,,Inhibition of TPA-induced EBA-early antigen production in human Raji cells at 10'-7 M,Other,20817520.0,
123,521220,3,3,,103283166,27924,Inactive,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
124,524790,7,2,,103283166,27924,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
125,524791,7,2,,103283166,27924,Active,,,6.30957,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
126,524792,7,2,,103283166,27924,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
127,524793,7,2,,103283166,27924,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
128,524794,7,1,,103283166,27924,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
129,524795,7,2,,103283166,27924,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
130,524796,7,1,,103283166,27924,Active,,,6.30957,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
131,530150,1,3,,103283166,27924,Unspecified,,,,,Effect on polymorphonuclear neutrophil killing of Aspergillus fumigatus assessed as survival rate of fungi (Rvb = 53% +/- 11%),Other,18426895.0,
132,540299,1,2,,99302480,27924,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
133,588519,1,2,,99300960,27924,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
134,588519,1,2,,99302480,27924,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
135,588579,1,1,,26755285,27924,Inconclusive,7705344.0,51426.0,39.8107,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
136,599010,6,5,,103283166,27924,Active,317373571.0,5578.0,0.0064,Ki,Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting,Confirmatory,21596562.0,
137,599012,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 100 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
138,599013,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 10 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
139,599014,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
140,599015,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.1 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
141,599040,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.01 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
142,599041,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.001 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
143,599042,1,10,,103283166,27924,Unspecified,317373571.0,5578.0,,,Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.0001 uM after 40 mins by agarose gel electrophoresis analysis relative to control,Other,21596562.0,
144,602314,1,2,,99300960,27924,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
145,602332,1,1,,26755285,27924,Inconclusive,168984549.0,,10.0,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
146,608031,1,4,,103283166,27924,Inactive,,,,,Induction of sensitization of human HeLa cells to camptothecin-induced apoptosis assessed as induction DNA fragmentation at 160 nM after 24 hrs by propidium iodide-staining based FACS assay,Other,21696964.0,
147,608032,1,4,,103283166,27924,Inactive,,,,,Induction of sensitization of human HeLa cells to staurosporine-induced apoptosis assessed as induction DNA fragmentation at 160 nM after 24 hrs by propidium iodide-staining based FACS assay,Other,21696964.0,
148,614623,3,3,,103283166,27924,Unspecified,,,1700.0,EC50,Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay,Confirmatory,21880495.0,
149,624101,1,2,,85787273,27924,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
150,624136,1,1,,85787273,27924,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
151,624137,1,1,,85787273,27924,Inactive,881546.0,3400.0,,,SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity,Screening,,
152,624138,1,1,,85787273,27924,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
153,624139,1,1,,85787273,27924,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
154,624141,1,1,,85787273,27924,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
155,624151,1,1,,85787273,27924,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
156,624156,1,1,,85787273,27924,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
157,624260,1,1,,85787273,27924,Inactive,109633019.0,7468.0,,,NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
158,651548,1,1,,85787273,27924,Inactive,21361095.0,2146.0,,,EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
159,654581,1,3,,103283166,27924,Active,,,,,Immunomodulatory activity in human NK92 cells assessed as induction of IFNgamma after 12 hrs by ELISA,Other,22361132.0,
160,662570,1,3,,103283166,27924,Active,,,,,Induction of human U937 cells attachment at 0.1 to 1000 nM treated for 24 hrs measured after 60 hrs,Other,22579485.0,
161,662571,1,3,,103283166,27924,Active,,,,,Antiproliferative activity against human U937 cells at 0.1 to 1000 nM after 60 hrs,Other,22579485.0,
162,662638,1,8,,103283166,27924,Active,400135.0,5581.0,,,Modulation of PKCepsilon in human K562 cells assessed as induction of protein activity after 24 hrs by Western blotting analysis,Other,22579485.0,
163,662639,1,8,,103283166,27924,Active,34395670.0,25780.0,,,Modulation of RASGRP3 in human K562 cells assessed as induction of protein activity after 24 hrs by Western blotting analysis,Other,22579485.0,
164,687827,1,2,,103283166,27924,Unspecified,,,,,Tumor promoting activity in human Raji cells assessed as induction of EBV-early antigen activation at 1 uM after 48 hrs by FITC staining based indirect immunofluorescence assay,Other,22625994.0,
165,687836,1,2,,103283166,27924,Unspecified,,,,,Tumor promoting activity in ICR mouse assessed as effect on DMBA-mediated skin carcinogenesis at 1.7 nmol administered 1 week after DMBA challenge twice weekly measured after 6 weeks by two-stage carcinogenesis test,Other,22625994.0,
166,687838,1,2,,103283166,27924,Unspecified,,,,,Tumor promoting activity in ICR mouse assessed as effect on DMBA-mediated skin carcinogenesis at 1.7 nmol administered 1 week after DMBA challenge twice weekly measured after 11 weeks by two-stage carcinogenesis test,Other,22625994.0,
167,687839,1,2,,103283166,27924,Unspecified,,,,,Tumor promoting activity in DMBA treated ICR mouse assessed as number of papillomas at 1.7 nmol administered 1 week after DMBA challenge twice weekly measured after 20 weeks by two-stage carcinogenesis test,Other,22625994.0,
168,697852,1,7,,103283166,27924,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
169,697853,1,7,,103283166,27924,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
170,718286,2,2,,103283166,27924,Unspecified,,,162.0,EC50,Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay,Confirmatory,23215460.0,
171,718287,1,2,,103283166,27924,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero cells to EC50 for Chikungunya virus 899",Other,23215460.0,
172,718288,2,2,,103283166,27924,Active,,,2.2,EC50,Antiviral activity against Sindbis virus HRsp infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay,Confirmatory,23215460.0,
173,718289,2,2,,103283166,27924,Active,,,0.0029,EC50,Antiviral activity against Chikungunya virus 899 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay,Confirmatory,23215460.0,
174,718290,2,2,,103283166,27924,Active,,,5.7,CC50,Cytotoxicity against african green monkey Vero cells by MTS assay,Confirmatory,23215460.0,
175,720532,1,1,,26755285,27924,Inconclusive,420597.0,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
176,720533,1,1,,26755285,27924,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
177,720717,1,3,,92310048,27924,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
178,745813,1,1,,103283166,27924,Unspecified,,,10.0,IC50,Cytotoxicity against human SNU387 cells after 48 hrs by MTT assay,Confirmatory,23701597.0,
179,746929,1,1,,103283166,27924,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 10'-6 M,Other,23582444.0,
180,746931,1,1,,103283166,27924,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 10'-7 M,Other,23582444.0,
181,746932,1,1,,103283166,27924,Unspecified,,,,,Induction of EBV-early antigen expressed in human Raji cells at 10'-6 M after 48 hrs by immunofluorescence assay relative to control,Other,23582444.0,
182,746933,1,1,,103283166,27924,Unspecified,,,,,Induction of EBV-early antigen expressed in human Raji cells at 10'-7 M after 48 hrs by immunofluorescence assay relative to control,Other,23582444.0,
183,751657,1,1,,103283166,27924,Active,,,0.00079,IC50,Displacement of [3H]PDBu from phorbol ester receptor in ICR mouse brain after 60 mins,Confirmatory,23403082.0,
184,751722,1,1,,103283166,27924,Unspecified,,,,,Displacement of [3H]PDBu from phorbol ester receptor in ICR mouse brain at 10 uM after 60 mins relative to control,Other,23403082.0,
185,1106045,1,2,,103283166,27924,Active,,,,,Immunomodulatory activity in Homo sapiens (human) PMN cells assessed as increase in reactive oxygen species formation at 1 uM at 40 min after luminal addition by chemiluminescence assay,Other,,
186,1106047,1,2,,103283166,27924,Active,,,,,Immunomodulatory activity in Homo sapiens (human) PMN cells assessed as increase in reactive oxygen species formation at 1 uM at 0 min after luminal addition by chemiluminescence assay,Other,,
187,1106049,1,2,,103283166,27924,Active,,,,,Immunomodulatory activity in Homo sapiens (human) PMN cells assessed as increase in NO release at 1 uM after 1 hr by ELISA plate reader analysis,Other,,
188,1106052,1,2,,103283166,27924,Active,,,,,Immunomodulatory activity in Homo sapiens (human) PMN cells assessed as increase in superoxide species generation at 1 uM after 2 hr by NBT assay,Other,,
189,1152271,1,3,,103283166,27924,Active,34395670.0,25780.0,,,Activation of RasGRP3 (unknown origin) overexpressed in HEK293 cells assessed as protein phosphorylation at T133 at 0.1 to 30 uM after 30 mins by Western blot analysis,Other,24794745.0,
190,1152272,1,3,,103283166,27924,Active,205371776.0,5580.0,,,Activation of PKC-delta in HEK293 cells assessed as protein phosphorylation at S299 at 0.1 to 30 uM after 30 mins by Western blot analysis,Other,24794745.0,
191,1152273,1,3,,103283166,27924,Active,205371776.0,5580.0,,,Activation of PKC-delta in HEK293 cells overexpressing RasGRP3 assessed as protein phosphorylation at S299 at 0.1 to 30 uM after 30 mins by Western blot analysis,Other,24794745.0,
192,1152274,1,3,,103283166,27924,Active,34395670.0,25780.0,,,Activation of RasGRP3 (unknown origin) overexpressed in HEK293 cells assessed as ERK1/2 phosphorylation at 0.1 to 30 uM after 30 mins by Western blot analysis,Other,24794745.0,
193,1152280,1,3,,103283166,27924,Active,317373571.0,5578.0,,,Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 1000 nM after 5 to 15 mins by confocal microscopic analysis,Other,24794745.0,
194,1152284,1,3,,103283166,27924,Active,205371776.0,5580.0,,,Binding affinity to recombinant human GFP-tagged PKC-delta expressed in human LNCAP cells assessed as induction of protein translocation from plasma membrane to internal membrane at 1000 nM after 2 to 10 mins by confocal microscopic analysis,Other,24794745.0,
195,1152286,1,3,,103283166,27924,Active,34395670.0,25780.0,,,Binding affinity to recombinant human GFP-tagged RasGRP3 expressed in human LNCAP cells assessed as induction of protein translocation from plasma membrane to internal membrane at 1000 nM after 2 to 10 mins by confocal microscopic analysis,Other,24794745.0,
196,1226755,1,1,,103283166,27924,Unspecified,,,,,Immunostimulatory activity in B6 mouse iNKT cells assessed as induction of IFN-gamma production incubated for 16 hrs followed by brefeldin A addition measured after 2 hrs by flow cytometric analysis in presence of ionomycin (Rvb = 0.6%),Other,25941558.0,
197,1228048,1,1,,103283166,27924,Active,,,,,Induction of human HL60 cell differentiation into macrophages at 16 nM after 72 hrs by May-Giemsa staining based microscopy,Other,25768725.0,
198,1228050,1,1,,103283166,27924,Active,,,,,Induction of human HL60 cell phagocytotic activity at 16 nM after 48 hrs by trypan based fluorescent microscopy,Other,25768725.0,
199,1228113,1,1,,103283166,27924,Unspecified,,,,,Growth inhibition of human U937 cells at 0.1 nM to 1000 nM after 72 hrs by particle counter based cell counting assay,Other,25808573.0,
200,1228117,1,1,,103283166,27924,Active,,,,,Induction of cell attachment of human U937 cells at 0.1 nM to 1000 nM after 60 hrs by particle counter based cell counting assay,Other,25808573.0,
201,1228120,1,1,,103283166,27924,Active,,,,,Induction of TNFalpha secretion in human U937 cells at 0.01 nM to 10000 nM by real time qPCR method,Other,25808573.0,
202,1231846,1,1,,103283166,27924,Active,,,0.0029,EC50,Antiviral activity against chikungunya virus Indian ocean strain 899 infected in Vero cells assessed as virus-induced cytopathic effect after 6 to 7 days,Confirmatory,25970561.0,
203,1231847,1,1,,103283166,27924,Unspecified,,,,,"Selectivity index, CC50 for african green monkey Vero cells to EC50 for chikungunya virus Indian ocean strain 899",Other,25970561.0,
204,1231848,1,1,,103283166,27924,Active,,,0.0009,EC50,Antiviral activity against HIV1 3B infected in MT4 cells assessed as cell viability after 5 days by MTT assay,Confirmatory,25970561.0,
205,1231849,1,1,,103283166,27924,Unspecified,,,,,"Selectivity index, CC50 for african green monkey Vero cells to EC50 for HIV1 3B",Other,25970561.0,
206,1231850,1,1,,103283166,27924,Active,,,0.0007,EC50,Antiviral activity against HIV2 ROD infected in MT4 cells assessed as cell viability after 5 days by MTT assay,Confirmatory,25970561.0,
207,1231851,1,1,,103283166,27924,Unspecified,,,,,"Selectivity index, CC50 for african green monkey Vero cells to EC50 for HIV2 ROD",Other,25970561.0,
208,1259389,1,1,,124637690,27924,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
209,1259407,1,1,,363898666,27924,Inactive,,,,,CCRIS mutagenicity studies,Other,,
210,1259408,1,1,,363896927,27924,Inactive,,,,,GENE-TOX mutagenicity studies,Other,,
211,1259410,1,1,,363898666,27924,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
212,1259411,1,1,,363898666,27924,Active,,,,,CCRIS carcinogenicity studies,Other,,
213,1259416,1,2,,170467444,27924,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
214,1259416,1,2,,340084380,27924,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
215,1259421,1,1,,170467444,27924,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
216,1259421,1,1,,340084380,27924,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
217,1259423,1,2,,354793107,27924,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
